TSE:VMD

Viemed Healthcare Stock Forecast, Price & News

C$11.83
+0.10 (+0.85 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
C$11.59
Now: C$11.83
C$11.98
50-Day Range
C$11.42
MA: C$12.31
C$13.13
52-Week Range
C$8.60
Now: C$11.83
C$16.19
Volume54,660 shs
Average Volume173,581 shs
Market CapitalizationC$468.02 million
P/E Ratio12.12
Dividend YieldN/A
BetaN/A
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone337 504 3802
Employees511
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$131.31 million
Cash FlowC$0.76 per share
Book ValueC$2.09 per share

Profitability

Miscellaneous

Market CapC$468.02 million
Next Earnings Date5/3/2021 (Confirmed)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.25 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -
C$11.83
+0.10 (+0.85 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VMD News and Ratings via Email

Sign-up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Viemed Healthcare (TSE:VMD) Frequently Asked Questions

Is Viemed Healthcare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viemed Healthcare in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Viemed Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VMD, but not buy additional shares or sell existing shares.
View analyst ratings for Viemed Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than Viemed Healthcare?

Wall Street analysts have given Viemed Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Viemed Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Viemed Healthcare's next earnings date?

Viemed Healthcare is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Viemed Healthcare
.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (TSE:VMD) announced its earnings results on Wednesday, March, 3rd. The company reported $0.16 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.09 by $0.07. The company earned $40.67 million during the quarter, compared to the consensus estimate of $41.50 million.
View Viemed Healthcare's earnings history
.

Who are Viemed Healthcare's key executives?

Viemed Healthcare's management team includes the following people:
  • Mr. Casey Hoyt, CEO & Director (Age 44, Pay $1.13M)
  • Mr. Michael B. Moore, Pres (Age 43, Pay $1.03M)
  • Mr. Trae Paul Fitzgerald, Chief Financial Officer (Age 32, Pay $433k)
  • Mr. William Todd Zehnder, COO & Director (Age 46, Pay $1M)
  • Mr. Jerome Richard Cambre II, VP of Sales (Age 50, Pay $462.47k)
  • Dr. William Dana Frazier, Chief Medical Officer & Director (Age 63)
  • John Collier, Chief Technology Officer
  • Claudio Munoz, Chief Information Officer
  • Mr. Brett Stoute, Chief Compliance Officer
  • Rob Birkhead, Chief Marketing Officer

Who are some of Viemed Healthcare's key competitors?

What is Viemed Healthcare's stock symbol?

Viemed Healthcare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VMD."

How do I buy shares of Viemed Healthcare?

Shares of VMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Viemed Healthcare's stock price today?

One share of VMD stock can currently be purchased for approximately C$11.83.

How much money does Viemed Healthcare make?

Viemed Healthcare has a market capitalization of C$468.02 million and generates C$131.31 million in revenue each year.

How many employees does Viemed Healthcare have?

Viemed Healthcare employs 511 workers across the globe.

What is Viemed Healthcare's official website?

The official website for Viemed Healthcare is www.viemed.com.

How can I contact Viemed Healthcare?

The company can be reached via phone at 337 504 3802.


This page was last updated on 4/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.